SARS-CoV-2 Binding and Neutralization Properties of Peptides Derived from N-Terminus of Human ACE2

被引:4
|
作者
Astrakhantseva, Irina V. [1 ]
Ershova, Alina E. [1 ]
Chuvpilo, Sergei A. [1 ]
Kruglova, Natalia A. [2 ]
Ishmukhametov, Aydar A. [3 ,4 ]
Drutskaya, Marina S. [5 ]
Kozlovskaya, Liubov I. [3 ,4 ]
Nedospasov, Sergei A. [1 ,5 ]
机构
[1] Sirius Univ Sci & Technol, Div Immunobiol & Biomed, Soci 354349, Russia
[2] Russian Acad Sci, Inst Gene Biol, Ctr Precis Genome Editing & Genet Technol Biomed, Lab Gene Therapy Socially Significant Dis, Moscow 119334, Russia
[3] Russian Acad Sci, Inst Poliomyelitis, Chumakov Sci Ctr Res & Dev Immune and Biol Prod, Dept Emerging & Reemerging Infect, Moscow 108819, Russia
[4] Sechenov Univ, Sechenov First Moscow State Med Univ, Inst Translat Med & Biotechnol, Moscow 119435, Russia
[5] Russian Acad Sci, Engelhardt Inst Mol Biol, Lab Mol Mech Immun, Moscow 119991, Russia
基金
俄罗斯基础研究基金会;
关键词
spike protein; decoy receptor; coronavirus variants; viral entry inhibition; human angiotensin-converting enzyme 2; FUNCTIONAL RECEPTOR; PROTEIN; DOMAIN;
D O I
10.3390/ijms24098269
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The binding properties of synthetic and recombinant peptides derived from N-terminal part of ACE2, the main receptor for SARS-CoV-2, were evaluated. Additionally, the ability of these peptides to prevent virus entry in vitro was addressed using both pseudovirus particles decorated with the S protein, as well as through infection of Vero cells with live SARS-CoV-2 virus. Surprisingly, in spite of effective binding to S protein, all linear peptides of various lengths failed to neutralize the viral infection in vitro. However, the P1st peptide that was chemically "stapled" in order to stabilize its alpha-helical structure was able to interfere with virus entry into ACE2-expressing cells. Interestingly, this peptide also neutralized pseudovirus particles decorated with S protein derived from the Omicron BA.1 virus, in spite of variations in key amino acid residues contacting ACE2.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Peptide Inhibitors of the Interaction of the SARS-CoV-2 Receptor-Binding Domain with the ACE2 Cell Receptor
    Bibilashvili, R. Sh.
    Sidorova, M. V.
    Dudkina, U. S.
    Palkeeva, M. E.
    Molokoedov, A. S.
    Kozlovskaya, L. I.
    Egorov, A. M.
    Ishmukhametov, A. A.
    Parfyonova, E. V.
    BIOCHEMISTRY MOSCOW-SUPPLEMENT SERIES B-BIOMEDICAL CHEMISTRY, 2021, 15 (04) : 274 - 280
  • [42] Allosteric communication between ACE2 active site and binding interface with SARS-CoV-2
    Mugnai, Mauro L.
    Thirumalai, D.
    JOURNAL OF CHEMICAL PHYSICS, 2023, 158 (21)
  • [43] Structural analysis of a simplified model reproducing SARS-CoV-2 S RBD/ ACE2 binding site
    Buonocore, Michela
    Santoro, Angelo
    Grimaldi, Manuela
    Covelli, Verdiana
    Firoznezhad, Mohammad
    Rodriquez, Manuela
    Santin, Matteo
    D'Ursi, Anna Maria
    HELIYON, 2022, 8 (11)
  • [44] Protein Footprinting, Conformational Dynamics, and Core Interface-Adjacent Neutralization "Hotspots" in the SARS-CoV-2 Spike Protein Receptor Binding Domain/Human ACE2 Interaction
    Narang, Dominic
    James, D. Andrew
    Balmer, Matthew T.
    Wilson, Derek J.
    JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 2021, 32 (07) : 1593 - 1600
  • [45] Comparison of the binding characteristics of SARS-CoV and SARS-CoV-2 RBDs to ACE2 at different temperatures by MD simulations
    Yan, Fang-Fang
    Gao, Feng
    BRIEFINGS IN BIOINFORMATICS, 2021, 22 (02) : 1122 - 1136
  • [46] Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus
    Beacon, Tasnim H.
    Delcuve, Genevieve P.
    Davie, James R.
    GENOME, 2021, 64 (04) : 386 - 399
  • [47] Advances in developing ACE2 derivatives against SARS-CoV-2
    Zhang, Haoran
    Lv, Panjing
    Jiang, Jingrui
    Liu, Yahui
    Yan, Ruixi
    Shu, Sainan
    Hu, Bing
    Xiao, Han
    Cai, Kun
    Yuan, Shuai
    Li, Yan
    LANCET MICROBE, 2023, 4 (05): : e369 - e378
  • [48] Expression pattern and function of SARS-CoV-2 receptor ACE2
    Li, Ruiting
    Qin, Chengfeng
    BIOSAFETY AND HEALTH, 2021, 3 (06) : 312 - 318
  • [49] Deciphering the Impact of Mutations on the Binding Efficacy of SARS-CoV-2 Omicron and Delta Variants With Human ACE2 Receptor
    Khan, Alamgir
    Khan, Salman Ali
    Zia, Komal
    Altowyan, Mezna Saleh
    Barakat, Assem
    Ul-Haq, Zaheer
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [50] ACE2: The Major Cell Entry Receptor for SARS-CoV-2
    Scialo, Filippo
    Daniele, Aurora
    Amato, Felice
    Pastore, Lucio
    Matera, Maria Gabriella
    Cazzola, Mario
    Castaldo, Giuseppe
    Bianco, Andrea
    LUNG, 2020, 198 (06) : 867 - 877